Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
2 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | A biotech’s race to tackle the most severe hepatitis - 10 days ago | |
3 | Tara Haelle MedPage Today Sci/health journalist.
Feminist.
Educator.
Photographer.
Author. DFW | Mahvash Disease Case Resolved With Liver Transplantation - about 1 year ago | |
4 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
5 | Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed | ||
6 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome - about 1 month ago Bulevirtide in Combination With PegInterferon Results In Undetectable Hepatitis D RNA Post-Treatment - 6 months ago | |
7 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH - about 1 month ago Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to Transplant - about 1 month ago Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial - about 1 year ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - about 1 year ago MASLD Predicted to Increase by 23% by Middle of the Century - about 1 year ago | |
8 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois | STAT+: With new Wegovy data in hand, Novo Nordisk will file for approval in MASH - about 2 months ago | |
9 | Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location | ||
10 | Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. |